Top Markets
Coin of the day
American Oriental Bioengineering, Inc. American Oriental Bioengineering, Inc.

American Oriental Bioengineering, Inc.

AOBI
Classement en actions #42790
American Oriental Bioengineering, Inc. (AOBI), headquartered in Beijing, China,... American Oriental Bioengineering, Inc. (AOBI), headquartered in Beijing, China, focuses its operations on the development, manufacturing, and commercialization of a broad spectrum of pharmaceutical and healthcare products. The company's core pharmaceutical offerings include a range of prescription medications. Among these are the Shuanghuanglian Lyophilized Injection Powder (SHL brand), prescribed to treat flu symptoms such as elevated fever, coughs, and sore throats, as well as to address upper respiratory tract infections, mild pneumonia, bronchitis, and tonsillitis. Another significant prescription product is the Cease Enuresis Soft Gel (CE Gel brand), formulated to alleviate bedwetting. AOBI's portfolio also extends to various over-the-counter (OTC) pharmaceutical solutions. These feature the Cease Enuresis Patch for managing bedwetting and urinary incontinence; Jinji Capsule, used for conditions like endometritis, annexitis, and pelvic inflammations; Jinji Yimucao, designed to relieve premenstrual syndrome (PMS) and other related menstrual and menopausal discomforts; and Boke Nasal Spray, which offers relief for sinus congestion associated with the common cold, nasal stuffiness, chronic rhinitis, allergic rhinitis, and nasosinusitis. Furthermore, the company develops and markets a selection of nutraceutical products, notably including soybean peptide-based items available as beverages, tablets, powders, and instant coffee. Beyond its manufacturing activities, AOBI is also involved in the wholesale and retail distribution of both its pharmaceutical and nutraceutical goods. The company's products are sold across the People's Republic of China through both direct channels and a network of distributors, reaching hospitals, clinics, pharmacies, supermarkets, fitness centers, specialty nutraceutical retailers, and various other retail outlets.
Prix de l'action
$0.0012
Dernière synchronisation: 2026-08-11
Capitalisation boursière
$88.00
Changement (1 jour)
0.00%
Changement (1 an)
140.00%
Pays
CN
Échange American Oriental Bioengineering, Inc. (AOBI)

Catégorie

Historique du prix de l'action pour American Oriental Bioengineering, Inc. (AOBI)
Prix de clôture le plus élevé : $0.00 le 2026-08-01

Prix de clôture le plus bas : $535.69 le 2001-12-01
Historique du prix de l'action de American Oriental Bioengineering, Inc. de 2001 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 0.00%
2025 140.00%
2024 13.33%
2023 120.59%
2022 -99.99%
2021 15,357.61%
2020 -99.61%
2019 371.70%
2018 -76.13%
2017 -79.44%
2016 107.11%
2015 -21.80%
2014 -72.19%
2013 -87.40%
2012 22.03%
2011 -72.66%
2010 -45.99%
2009 -30.02%
2008 -46.92%
2007 -3.63%
2006 161.57%
2005 187.09%
2004 -54.09%
2003 984.09%
2002 -85.26%
2001 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR